Showing results (271-280 of 295) with videos related to
Sort By:
Pageof 30
Proteomics. Clinical Applications|August 2, 2011
Assessment of high-throughput high-resolution MALDI-TOF-MS of urinary peptides for the detection of muscle-invasive bladder cancerRichard T Bryan, Wenbin Wei, Neil J Shimwell, et al.Journal of Hepatology|December 3, 2019
The chances of hepatic resection curing hepatocellular carcinomaAlessandro Cucchetti, Jianhong Zhong, Sarah Berhane, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2014
Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI gradePhilip J Johnson, Sarah Berhane, Chiaki Kagebayashi, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2004
Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nonnasopharyngeal head and neck carcinomasKwok Hung Yu, Y M Dennis Lo, Gary M Tse, et al.BMJ (Clinical Research Ed.)|August 2, 2023
Mortality rates among patients successfully treated for hepatitis C in the era of interferon-free antivirals: population based cohort studyVictoria Hamill, Stanley Wong, Jennifer Benselin, et al.Journal of Hepatology|September 22, 2018
Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resectionAnthony W H Chan, Jianhong Zhong, Sarah Berhane, et al.The Lancet. Gastroenterology & Hepatology|June 27, 2017
Sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma (TACE 2): a randomised placebo-controlled, double-blind, phase 3 trialTim Meyer, Richard Fox, Yuk Ting Ma, et al.British Journal of Cancer|March 30, 2016
Long-term impact of liver function on curative therapy for hepatocellular carcinoma: application of the ALBI gradeHidenori Toyoda, Paul B S Lai, James O'Beirne, et al.International Journal of Cancer|November 13, 2008
TOP2A overexpression in hepatocellular carcinoma correlates with early age onset, shorter patients survival and chemoresistanceNathalie Wong, Winnie Yeo, Wai-Lap Wong, et al.Journal of the National Cancer Institute|October 20, 2005
A randomized phase III study of doxorubicin versus cisplatin/interferon alpha-2b/doxorubicin/fluorouracil (PIAF) combination chemotherapy for unresectable hepatocellular carcinomaWinnie Yeo, Tony S Mok, Benny Zee, et al.Pageof 30